As of April 2024 Edwards Lifesciences has a market cap of $52.74 Billion. This makes Edwards Lifesciences the world's 360th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $52.74 B | 14.06% |
2023 | $46.24 B | 0.25% |
2022 | $46.12 B | -42.97% |
2021 | $80.88 B | 42.25% |
2020 | $56.85 B | 16.56% |
2019 | $48.78 B | 53.33% |
2018 | $31.81 B | 33.38% |
2017 | $23.85 B | 19.05% |
2016 | $20.03 B | 17.76% |
2015 | $17.01 B | 23.89% |
2014 | $13.73 B | 91.05% |
2013 | $7.18 B | -30.26% |
2012 | $10.30 B | 27.79% |
2011 | $8.06 B | -13.25% |
2010 | $9.29 B | 88.45% |
2009 | $4.93 B | 61.28% |
2008 | $3.05 B | 17.5% |
2007 | $2.60 B | -4.1% |
2006 | $2.71 B | 9.58% |
2005 | $2.47 B | 1% |
2004 | $2.45 B | 37.07% |
2003 | $1.78 B | 16.73% |
2002 | $1.53 B | -6.5% |
2001 | $1.63 B |
On Apr 22nd, 2024 the market cap of Edwards Lifesciences was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Medtronic MDT | $107.49 B | 103.79% | ๐ฎ๐ช Ireland |
Boston Scientific BSX | $100.91 B | 91.32% | ๐บ๐ธ USA |
Merit Medical MMSI | $4.33 B | -91.78% | ๐บ๐ธ USA |
LeMaitre Vascular LMAT | $1.44 B | -97.27% | ๐บ๐ธ USA |
ICU Medical
ICUI | $2.40 B | -95.45% | ๐บ๐ธ USA |
CryoLife CRY | $0.70 B | -98.67% | ๐บ๐ธ USA |